2021
DOI: 10.1101/2021.08.19.456982
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Somatic mutation rates scale with lifespan across mammals

Abstract: The rates and patterns of somatic mutation in normal tissues are largely unknown outside of humans. Comparative analyses can shed light on the diversity of mutagenesis across species and on long-standing hypotheses regarding the evolution of somatic mutation rates and their role in cancer and ageing. Here, we used whole-genome sequencing of 208 intestinal crypts from 56 individuals to study the landscape of somatic mutation across 16 mammalian species. We found somatic mutagenesis to be dominated by seemingly … Show more

Help me understand this report
View published versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

6
79
0
2

Year Published

2021
2021
2022
2022

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 52 publications
(88 citation statements)
references
References 105 publications
6
79
0
2
Order By: Relevance
“…Therefore, based on our optimisation criteria, we would expect that in longer lived organisms (with the same homeostatic TDC number) SCs should divide more slowly and there should be a greater number of amplification steps to minimise division accumulation. A recent measurement of somatic mutation rate across animals with different lifespans supports this hypothesis, with longer lived animals having a lower rate of somatic mutation accumulation (Cagan et al, 2021). Furthermore, we find that underestimating the timescale of optimisation relative to lifetime leads to a large increase in divisional load at ages beyond the optimisation timescale.…”
Section: Discussionsupporting
confidence: 81%
“…Therefore, based on our optimisation criteria, we would expect that in longer lived organisms (with the same homeostatic TDC number) SCs should divide more slowly and there should be a greater number of amplification steps to minimise division accumulation. A recent measurement of somatic mutation rate across animals with different lifespans supports this hypothesis, with longer lived animals having a lower rate of somatic mutation accumulation (Cagan et al, 2021). Furthermore, we find that underestimating the timescale of optimisation relative to lifetime leads to a large increase in divisional load at ages beyond the optimisation timescale.…”
Section: Discussionsupporting
confidence: 81%
“…As has been recently reviewed in detail, accumulation of somatic mutations might also impact aging for example by affecting the functioning of cells by influencing tightly controlled gene-regulatory networks and increasing cell-to-cell transcriptional heterogeneity (transcriptional noise) (Vijg and Dong, 2020). This is further supported by the observation that the mutation load at the end of life is similar between different mammals with wildly different lifespans (Cagan et al, 2021). Defects in DNA repair have also been associated with accelerated aging (Tiwari and Wilson, 2019).…”
Section: The Impact Of Somatic Mutations On Disease and Agingmentioning
confidence: 95%
“…The patterns of aging-related somatic mutagenesis are conserved even across mammalian species with the mutation rate inversely correlated with species lifespan. This suggests that beyond risk of cancer, somatic mutation rate may be a determinant of lifespan ( 14 ). Mathematical reconstruction of HSPC lineage histories suggests that CH mutations may arise as early as childhood (even in utero ) with some mutations undergoing a gradual expansion throughout life ( 11 , 15 ).…”
Section: Mainmentioning
confidence: 99%
“…Our ability to detect CH mutations and the observed prevalence of CH is dependent on the sensitivity of sequencing as determined by sequencing depth. For example, analysis of whole exome sequencing data sequenced at a depth of under 100-fold coverage generally reports age‐dependent single nucleotide variants (SNVs) or small insertions/deletions (indels) in approximately 6% of subjects over 65 years of age ( 2 , 3 , 14 ). In contrast, next-generation sequencing (NGS) technologies with advanced error-correction methods such as unique molecular indices, can accurately detect mutations below 0.5% variant allele fraction (VAF) when performed at a high depth ( 16 ).…”
Section: Mainmentioning
confidence: 99%